17 May 2025
: Case report 
Challenges in Treating Dermatomyositis-Related Rhabdomyolysis: A Case Report of Steroid-Induced Myopathy
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Adverse events of drug therapy, Rare coexistence of disease or pathology
Dawid Żyrek
ABDEF 1,2*, Wioletta Sandłak BDE 2
DOI: 10.12659/AJCR.947064
Am J Case Rep 2025; 26:e947064
Figure 2 Changes in the concentration of selected biomarkers during hospitalization in relation to pharmacological interventions. CPK – creatine phosphokinase; ALT – alanine aminotransferase; AST – aspartate aminotransferase, methylprednisolone 1000 mg daily, prednisone – 80 mg daily, hydrocortisone 200 mg daily; IVIG – intravenous immunoglobulin 0.4 g/kg of body weight daily.